Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.330 NOK
−106.68 M NOK
190.81 M NOK
190.77 M
About HOFSETH BIOCARE AS
Sector
CEO
Jon Olav Ødegård
Headquarters
Ålesund
Website
Founded
2009
ISIN
NO0010598683
FIGI
BBG0029P0143
Hofseth Biocare ASA engages in the development, marketing, and sale of biomarine ingredients. Its products include ProGo Bioactive Peptides, OmeGo Salmon Oil, CalGo Calcium Collagen Complex, and Shop Branded Products. The company was founded by Roger Hofseth in 2000 and is headquartered in Alesund, Norway.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of HBC is 1.265 NOK — it has decreased by −0.74% in the past 24 hours. Watch HOFSETH BIOCARE AS stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OSL exchange HOFSETH BIOCARE AS stocks are traded under the ticker HBC.
HBC stock has risen by 1.90% compared to the previous week, the month change is a −20.94% fall, over the last year HOFSETH BIOCARE AS has showed a −51.35% decrease.
HBC stock is 8.37% volatile and has beta coefficient of −0.33. Track HOFSETH BIOCARE AS stock price on the chart and check out the list of the most volatile stocks — is HOFSETH BIOCARE AS there?
Today HOFSETH BIOCARE AS has the market capitalization of 550.85 M, it has decreased by −3.60% over the last week.
Yes, you can track HOFSETH BIOCARE AS financials in yearly and quarterly reports right on TradingView.
HOFSETH BIOCARE AS is going to release the next earnings report on Feb 14, 2025. Keep track of upcoming events with our Earnings Calendar.
HBC net income for the last quarter is −35.01 M NOK, while the quarter before that showed −17.56 M NOK of net income which accounts for −99.33% change. Track more HOFSETH BIOCARE AS financial stats to get the full picture.
No, HBC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 21, 2024, the company has 65.00 employees. See our rating of the largest employees — is HOFSETH BIOCARE AS on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HOFSETH BIOCARE AS EBITDA is −91.00 M NOK, and current EBITDA margin is −52.39%. See more stats in HOFSETH BIOCARE AS financial statements.
Like other stocks, HBC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HOFSETH BIOCARE AS stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HOFSETH BIOCARE AS technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HOFSETH BIOCARE AS stock shows the sell signal. See more of HOFSETH BIOCARE AS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.